Neoprobe Corp.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2010 | $14 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Neoprobe Corp. had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Jul 2010).
SEC Form D (revenue range) · Jul 2010
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2010
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
5 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Platinum Liquid Opportunity Management (NY) LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Platinum Management (NY) LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Platinum-Montaur Life Sciences, LLC | Other | not stated | not stated | Held Series B preferred stock (Form 3, 2013) | SEC Form 3 |
| Platinum Partners Liquid Opportunity Master Fund L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Platinum Partners Value Arbitrage Fund, LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 3 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Anthony K. Blair | Executive officer | Jul 2010 |
| Brent L. Larson | Executive officer | Jul 2010 |
| David C. Bupp | Executive officer | Jul 2010 |
| Douglas L. Rash | Executive officer | Jul 2010 |
| Frederick O. Cope | Executive officer | Jul 2010 |
| Rodger A. Brown | Executive officer | Jul 2010 |
| Carl J. Aschinger, Jr. | Director | Jul 2010 |
| David C. Bupp | Director | Jul 2010 |
| Fred B. Miller | Director | Jul 2010 |
| Gordon A. Troup | Director | Jul 2010 |
| J. Frank Whitley, Jr. | Director | Jul 2010 |
| Kirby I. Bland | Director | Jul 2010 |
| Owen E. Johnson | Director | Jul 2010 |
| Reuven C. Avital | Director | Jul 2010 |